Try our Advanced Search for more refined results
- Law360
- Law360 UK
- Law360 Pulse
- Law360 Employment Authority
- Law360 Tax Authority
- Law360 Insurance Authority
- Law360 Real Estate Authority
- Law360 Healthcare Authority
- Law360 Bankruptcy Authority
- Products
- Lexis®
- Law360 In-Depth
- Law360 Podcasts
- Rankings
- Leaderboard Analytics
- Regional Powerhouses
- Law360's MVPs
- Women in Law Report
- Law360 400
- Diversity Snapshot
- Practice Groups of the Year
- Rising Stars
- Titans of the Plaintiffs Bar
- Sections
- Adv. Search & Platform Tools
- About all sections
- Browse all sections
- Banking
- Bankruptcy
- Class Action
- Competition
- Employment
- Energy
- Expert Analysis
- Insurance
- Intellectual Property
- Product Liability
- Securities
- Beta Tools
- Track docs
- Track attorneys
- Track judges
RxStrategies, Inc. v. CVS Pharmacy, Inc. et al
Case Number:
8:18-cv-01087
Court:
Nature of Suit:
Judge:
Firms
Companies
Sectors & Industries:
-
March 19, 2020
CVS Settles Drug Administrator's Antitrust Suit
Following notice of a settlement, a Florida federal judge on Thursday closed a lawsuit accusing CVS of breaking antitrust law by requiring health care providers to use its federal discounted drug program administrator Wellpartner.
-
December 04, 2019
CVS Must Face RxStrategies' Revised Antitrust Claim
Brushed-up assertions of CVS' dominance in some local pharmacy markets were enough Wednesday for a Florida federal judge to refuse to toss an antitrust claim brought against the company by a rival administrator for a federal discounted drugs program.
-
August 08, 2019
CVS Aiming To Shake RxStrategies' Tying Claim For Good
CVS Pharmacy Inc. and its 340B Drug Pricing Program administrator Wellpartner LLC are again asking a Florida federal judge to shut down a rival administrator's allegation that the pair is engaging in unlawful tying, arguing that the competitor's latest claim is still too vague.
-
May 29, 2019
RxStrategies Sees Tying Claim Cut From CVS Suit
A Florida federal judge on Wednesday cut a tying claim from RxStrategies Inc.'s lawsuit against CVS but allowed trade secrets and contract claims to continue.
-
November 20, 2018
CVS Fights Bid To Block It From Contacting 340B Customers
CVS Pharmacy Inc. urged a Florida federal court Monday not to issue an injunction requested by an administrator for the federal 340B Drug Pricing Program that would stop the pharmacy giant from allegedly misappropriating trade secrets to steal customers.
-
October 15, 2018
Co. Bids To Keep CVS Unit From Clients In Trade Secrets Row
RxStrategies, a leading program administrator for the federal 340B Drug Pricing Program, renewed its efforts Friday to stop CVS and its in-house administrator Wellpartner from allegedly misappropriating its trade secrets to steal customers, presenting evidence it says refutes several of their defenses.
-
July 02, 2018
CVS Wants Antitrust Suit Over 340B Drug Program Tossed
CVS Pharmacy Inc. and its 340B Drug Pricing Program administrator Wellpartner LLC on Friday urged a Florida federal court to dismiss an antitrust and trade secrets lawsuit brought by a rival administrator, saying the poorly defined allegations stem from the company's fear of innovation in the market, not illegal activity.
-
May 07, 2018
RxStrategies Says CVS, Rival Swiping Its Customers
RxStrategies Inc., a leading program administrator for the federal 340B Drug Pricing Program, asked a Florida federal judge Monday for a preliminary injunction to keep CVS and rival Wellpartner from engaging in anti-competitive conduct and using what the company says are its misappropriated trade secrets to steal customers.